Roxro Raises $42.7 Million

Roxro Pharma Inc., a Menlo Park, Calif.-based drug company focused on pain alleviation, has closed its Series B funding round with $42.7 million. Prospect Venture Partners and Sutter Hill Ventures co-led the deal, and was joined by Thomas Weisel Healthcare Venture Partners. www.roxropharma.com